Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
**Background:** A consensus is lacking on optimal treatment sequencing for follicular lymphoma (FL), the most common indolent lymphoma. FL is incurable, and many patients require multiple lines of therapy for successive relapses. Guidelines provide numerous recommendations for first-, second-, and t...
Saved in:
Main Authors: | Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.38070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
by: Nathan H. Fowler, et al.
Published: (2020-09-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
by: Hajnalka Rajnai, et al.
Published: (2015-01-01) -
Follicular Lymphoma In Situ Presenting as Dermatopathic Lymphadenopathy
by: Orah Nnamdi Obumneme, et al.
Published: (2013-01-01) -
Fairness and Justice in the Procedure of the Iran–United States Claims Tribunal
by: Fatemeh Niavarani, et al.
Published: (2024-09-01)